loadpatents
name:-0.048079967498779
name:-0.032193899154663
name:-0.011473894119263
Debinski; Waldemar Patent Filings

Debinski; Waldemar

Patent Applications and Registrations

Patent applications and USPTO patent grants for Debinski; Waldemar.The latest application filed is for "molecular signature of cancer".

Company Profile
9.33.45
  • Debinski; Waldemar - Winston-Salem NC
  • DEBINSKI; WALDEMAR - Blacksburg VA
  • Debinski; Waldemar - Hershey PA
  • Debinski; Waldemar - Hummelstown PA
  • Debinski; Waldemar - Gaithersburg MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Molecular Signature Of Cancer
App 20220062376 - Debinski; Waldemar ;   et al.
2022-03-03
Molecular signature of cancer
Grant 11,207,380 - Debinski , et al. December 28, 2
2021-12-28
Multi-level Specific Targeting Of Cancer Cells
App 20210395324 - Debinski; Waldemar ;   et al.
2021-12-23
Multi-level specific targeting of cancer cells
Grant 11,136,367 - Debinski , et al. October 5, 2
2021-10-05
Epha3 And Multi-valent Targeting Of Tumors
App 20200347113 - Debinski; Waldemar ;   et al.
2020-11-05
Antibodies Against Human And Canine Il-13ra2
App 20200299394 - Debinski; Waldemar ;   et al.
2020-09-24
EPHA3 and multi-valent targeting of tumors
Grant 10,752,667 - Debinski , et al. A
2020-08-25
Antibodies against human and canine IL-13RA2
Grant 10,676,529 - Debinski , et al.
2020-06-09
Multi-level Specific Targeting Of Cancer Cells
App 20200095302 - Debinski; Waldemar ;   et al.
2020-03-26
Induced Cell Morphology Electroporation
App 20200046967 - IVEY; JILL W. ;   et al.
2020-02-13
Multi-level specific targeting of cancer cells
Grant 10,519,210 - Debinski , et al. Dec
2019-12-31
Multi-level Specific Targeting Of Cancer Cells
App 20190153057 - DEBINSKI; WALDEMAR ;   et al.
2019-05-23
Nucleic acids encoding a fusion protein useful for multi-level specific targeting of cancer cells
Grant 10,233,224 - Debinski , et al.
2019-03-19
Epha3 And Multi-valent Targeting Of Tumors
App 20180244745 - Debinski; Waldemar ;   et al.
2018-08-30
Molecular Signature Of Cancer
App 20180243368 - Debinski; Waldemar ;   et al.
2018-08-30
Antibodies Against Human And Canine Il-13ra2
App 20180155437 - Debinski; Waldemar ;   et al.
2018-06-07
EPHA3 And multi-valent targeting of tumors
Grant 9,975,942 - Debinski , et al. May 22, 2
2018-05-22
Molecular signature of cancer
Grant 9,974,830 - Debinski , et al. May 22, 2
2018-05-22
IL-13 receptor binding peptides
Grant 9,878,013 - Debinski , et al. January 30, 2
2018-01-30
Antibodies against human and canine IL-13RA2
Grant 9,868,788 - Debinski , et al. January 16, 2
2018-01-16
Multi-level Specific Targeting Of Cancer Cells
App 20180002394 - Debinski; Waldemar ;   et al.
2018-01-04
Multi-level specific targeting of cancer cells
Grant 9,771,404 - Debinski , et al. September 26, 2
2017-09-26
Epha3 And Multi-valent Targeting Of Tumors
App 20160297863 - Debinski; Waldemar ;   et al.
2016-10-13
Molecular Signature Of Cancer
App 20160193289 - Debinski; Waldemar ;   et al.
2016-07-07
Il-13 Receptor Binding Peptides
App 20160175399 - Debinski; Waldemar ;   et al.
2016-06-23
IL-13 receptor binding peptides
Grant 9,296,785 - Debinski , et al. March 29, 2
2016-03-29
Molecular signature of cancer
Grant 9,290,558 - Debinski , et al. March 22, 2
2016-03-22
Antibodies Against Human And Canine Il-13ra2
App 20160039938 - Debinski; Waldemar ;   et al.
2016-02-11
Multi-level Specific Targeting Of Cancer Cells
App 20150203557 - Debinski; Waldemar ;   et al.
2015-07-23
Compounds useful for multi-level specific targeting of cancer cells
Grant 9,005,600 - Debinski , et al. April 14, 2
2015-04-14
Method Of Treating Brain Tumors
App 20140255471 - Gmeiner; William H. ;   et al.
2014-09-11
Il-13 Receptor Binding Peptides
App 20130209541 - Debinski; Waldemar ;   et al.
2013-08-15
Multi-level Specific Targeting Of Cancer Cells
App 20130164257 - Debinski; Waldemar ;   et al.
2013-06-27
Molecular Signature Of Cancer
App 20130136692 - Debinski; Waldemar ;   et al.
2013-05-30
Cancer immunotherapy
Grant 8,435,534 - Debinski , et al. May 7, 2
2013-05-07
Multi-level specific targeting of cancer cells with IL-13
Grant 8,362,207 - Debinski , et al. January 29, 2
2013-01-29
Molecular signature of cancer
Grant 8,343,461 - Debinski , et al. January 1, 2
2013-01-01
Multi-level Specific Targeting Of Cancer Cells
App 20110300099 - DEBINSKI; WALDEMAR ;   et al.
2011-12-08
Cancer Immunotherapy
App 20110280885 - Debinski; Waldemar ;   et al.
2011-11-17
Nucleic acid cancer immunotherapy
Grant 7,960,361 - Debinski , et al. June 14, 2
2011-06-14
Antibody Cancer Immunotherapy
App 20110110955 - Debinski; Waldemar ;   et al.
2011-05-12
Nucleic acids encoding IL13 mutants
Grant 7,598,058 - Debinski , et al. October 6, 2
2009-10-06
Molecular Signature Of Cancer
App 20090123371 - Debinski; Waldemar ;   et al.
2009-05-14
Antibody Cancer Immunotherapy
App 20080206255 - Debinski; Waldemar ;   et al.
2008-08-28
Fra-1 Expression In Brain Cancer
App 20080188438 - Debinski; Waldemar ;   et al.
2008-08-07
Nucleic Acid Cancer Immunotherapy
App 20080166374 - Debinski; Waldemar ;   et al.
2008-07-10
Cancer Immunotherapy
App 20080131448 - Debinski; Waldemar ;   et al.
2008-06-05
Cancer immunotherapy
Grant 7,338,929 - Debinski , et al. March 4, 2
2008-03-04
Eph receptor tumor biomarkers
App 20060121539 - Debinski; Waldemar ;   et al.
2006-06-08
Fra-1 expression in brain cancer
App 20050260649 - Debinski, Waldemar ;   et al.
2005-11-24
Fra-1 expression in brain cancer
App 20050255510 - Debinski, Waldemar ;   et al.
2005-11-17
Fra-1 expression in brain cancer
App 20050255511 - Debinski, Waldemar ;   et al.
2005-11-17
Method for identifying a test compound that modulates expression of a Fra-1 gene in a brain cancer cell
Grant 6,884,581 - Debinski , et al. April 26, 2
2005-04-26
Nucleic acids encoding IL13 mutants
Grant 6,884,603 - Debinski , et al. April 26, 2
2005-04-26
Nucleic acids encoding IL13 mutants
App 20050053589 - Debinski, Waldemar ;   et al.
2005-03-10
EGFR ligands and methods of use
App 20030211112 - Debinski, Waldemar
2003-11-13
Amino acid substitution mutants of interleukin 13
Grant 6,630,576 - Debinski October 7, 2
2003-10-07
IL-13 receptor specific chimeric proteins & uses thereof
App 20030129132 - Puri, Raj K. ;   et al.
2003-07-10
IL13 mutants
Grant 6,576,232 - Debinski , et al. June 10, 2
2003-06-10
Antibodies that bind IL-13 mutants
App 20030031666 - Debinski, Waldemar ;   et al.
2003-02-13
IL-13 receptor specific chimeric proteins and uses thereof
Grant 6,518,061 - Puri , et al. February 11, 2
2003-02-11
Immunotherapy using interleukin 13 receptor subunit alpha 2
App 20020197266 - Debinski, Waldemar
2002-12-26
Cancer immunotherapy
App 20020182219 - Debinski, Waldemar ;   et al.
2002-12-05
VEGF-D expression in brain cancer
App 20020164624 - Debinski, Waldemar ;   et al.
2002-11-07
Nucleic acids encoding IL13 mutants
App 20020159972 - Debinski, Waldemar ;   et al.
2002-10-31
FRA -1 expression in brain cancer
App 20020151457 - Debinski, Waldemar ;   et al.
2002-10-17
Amino acid substitution mutants of interleukin 13
App 20020119120 - Debinski, Waldemar
2002-08-29
Compositions and methods for specifically targeting tumors
Grant 6,428,788 - Debinski , et al. August 6, 2
2002-08-06
Characterizing a brain tumor
App 20020031492 - Debinski, Waldemar
2002-03-14
Method For Diagnosing, Imaging, And Treating Tumors Using Restrictive Receptor For Interleukin 13
App 20010053371 - DEBINSKI, WALDEMAR ;   et al.
2001-12-20
Mutagenized IL 13-based chimeric molecules
Grant 6,296,843 - Debinski October 2, 2
2001-10-02
IL-13 receptor specific chimeric proteins
Grant 5,919,456 - Puri , et al. July 6, 1
1999-07-06
IL-13 receptor specific chimeric proteins and uses thereof
Grant 5,614,191 - Puri , et al. March 25, 1
1997-03-25
Recombinant chimeric proteins deliverable across cellular membranes into cytosol of target cells
Grant 5,328,984 - Pastan , et al. July 12, 1
1994-07-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed